ArticleNucleic acids research2026
Intrinsically disordered protein droplet-enhanced oligonucleotide assembly enables rapid oligonucleotide-to-protein expression.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NUPR1 in breast cancer: mechanisms and potential applications.Frontiers in physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Recent advances in in silico protein design and bioinformatics have enabled the rapid generation of candidate sequences for functional proteins. However, experimental validation remains a bottleneck, largely due to time-consuming DNA assembly and cell-based cloning processes. Technologies that reduce the time required to convert synthetic oligonucleotides (oligos) into expressed proteins are therefore of considerable interest. Here, we demonstrate that phase-separated droplets formed by the intrinsically disordered protein (Ddx4N1) concentrate both oligos and ligation enzymes, enabling efficient oligo assembly at nanomolar to sub-nanomolar concentrations that are typically inaccessible to conventional ligation-based methods. The assembled products can be directly introduced into femtoliter-scale microreactors for digital cell-free gene expression, allowing protein expression from single assembled DNA molecules without polymerase chain reaction amplification or cellular cloning. Simultaneous expression of two distinct proteins from separately assembled DNA templates in a one-pot reaction was also demonstrated. The complete workflow-from oligo assembly to detectable protein expression-can be performed within half a day. While further development will be required to enhance reaction parallelization and enable systematic retrieval of sequence information from expressed products, this amplification-free, low-input system establishes a technical foundation for integrating oligo-pool-based gene assembly with digital protein prototyping platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.